The Role of RNASEL Mutation in the Complex Genetic Landscape of Prostate Adenocarcinoma

authors:

avatar Michael Karsy 1 , *

Department of Neurosurgery, University of Utah, Salt Lake City, USA
Gene, Cell and Tissue: Vol.1, issue 3; e23703
published online: October 29, 2014
article type: Letter
received: September 17, 2014
accepted: September 30, 2014
DOI: https://doi.org/10.17795/gct-23703

how to cite: Karsy M. The Role of RNASEL Mutation in the Complex Genetic Landscape of Prostate Adenocarcinoma. Gene Cell Tissue. 2014;1(3):e23703. https://doi.org/10.17795/gct-23703.

Acknowledgements

References

  • 1.

    DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252-71. [PubMed ID: 24890451]. https://doi.org/10.3322/caac.21235.

  • 2.

    Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science. 1996;274(5291):1371-4. [PubMed ID: 8910276].

  • 3.

    Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet. 2000;67(6):1367-75. [PubMed ID: 11067781]. https://doi.org/10.1086/316916.

  • 4.

    Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 2002;30(2):181-4. [PubMed ID: 11799394]. https://doi.org/10.1038/ng823.

  • 5.

    Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, et al. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet. 2002;32(4):581-3. [PubMed ID: 12415269]. https://doi.org/10.1038/ng1021.

  • 6.

    Schaid DJ. The complex genetic epidemiology of prostate cancer. Hum Mol Genet. 2004;13 Spec No 1:R103-21. [PubMed ID: 14749351]. https://doi.org/10.1093/hmg/ddh072.

  • 7.

    Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, et al. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making. Biomed Res Int. 2014;2014:627510. [PubMed ID: 24701578]. https://doi.org/10.1155/2014/627510.

  • 8.

    Seidabadi A, Rezatofighi SE, Motamedi H, Rashidi I. R462Q Mutation in Prostate Cancer Specimens. Gene Cell Tissue. 2014;1(2).

  • 9.

    Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE. RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate. 2008;68(4):354-9. [PubMed ID: 18189233]. https://doi.org/10.1002/pros.20687.

  • 10.

    Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014;46(10):1103-9. [PubMed ID: 25217961]. https://doi.org/10.1038/ng.3094.